Rankings
▼
Calendar
APGE Q1 2025 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$63M
Net Income
-$55M
EPS (Diluted)
$-0.95
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$53M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$714M
Total Liabilities
$41M
Stockholders' Equity
$673M
Cash & Equivalents
$107M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$63M
-$38M
-65.3%
Net Income
-$55M
-$32M
-72.4%
← FY 2025
All Quarters
Q2 2025 →